Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...
Le Lézard18 小时
Aidoc Secures Landmark FDA Clearance for First Foundation Model-Powered Clinical AI ...
Aidoc, a global leader in clinical AI, has secured a defining FDA clearance for a CADt AI solution powered by a foundation model ? a major step forward in the evolution of clinical AI. This milestone ...
Global Transmucosal Drugs Market to Reach ~USD 28 Billion by 2032 | DelveInsight
DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual ...
News Medical on MSN4 小时
Milk boosts gut-friendly bacteria while cheese alters microbiome balance, study reveals
Researchers found that dairy consumption influences gut microbiota composition, with milk promoting beneficial bacteria and ...
DelveInsight Business Research, LLP: Global Transmucosal Drugs Market to Reach ~USD 28 ...
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...